32P'incorporation into polyphosphoinositides of erythrocytes from essential hypertension
Minenko, A.; Hajdu, I.; Oehme, P.
Acta Biologica et Medica Germanica 40(3): 341-344
1981
ISSN/ISBN: 0001-5318 PMID: 6272513 Document Number: 171520
The level of polyphosphoinositides (PPI) and the incorporation rate of 32P into PPI of erythrocytes from essential hypertensive patients was studied. The PPI were found to have a decreased level and an increased 32P incorporation rate compared with the controls.
Document emailed within 1 workday
Related Documents
Katiukhin, L.N.; Maslova, M.N. 1989: The characteristics of blood erythrocytes in essential hypertension Laboratornoe Delo 11: 49-51Kravtsov, G.M.; Dulin, N.O.; Postnov, I.V. 1988: Protein kinase a and C activity of erythrocytes in patients with essential hypertension Kardiologiia 28(5): 96-98
Wambach, G.; Helber, A.; Bönner, G.; Hummerich, W. 1978: Sodium-potassium-ATPase activity in erythrocyte ghosts and electrolyte concentrations in erythrocytes of patients with essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 800-803
Hannaert, P.; Laurent, S.; Girerd, X.; Safar, M.; Abitbol, J.P.; Garay, R. 1989: Therapeutic response to canrenone of patients with essential hypertension as a function of sodium transport anomalies and ouabain sensitivity of erythrocytes Archives des Maladies du Coeur et des Vaisseaux 82(9): 1603-1607
Chodakowska, J.; Wocial, B.; Ignatowska-Switalska, H.; Knypl, K.; Brym, E.; Czerniewska, E.; Wacławek-Maczkowska, J.; Jabłońska-Skwiecińska, E.; Drygieniec, D.; Januszewicz, W. 1989: Effect of treatment with enalapril maleate on the levels of circulating catecholamines, beta endorphins, prostaglandins, and concentration of sodium in erythrocytes in patients with essential hypertension Polski Tygodnik Lekarski 44(12-13): 297-300
Vial, H.J.; Thuet, M.J.; Broussal, J.L.; Philippot, J.R. 1982: Phospholipid biosynthesis by Plasmodium knowlesi-infected erythrocytes: the incorporation of phospohlipid precursors and the identification of previously undetected metabolic pathways Journal of Parasitology 68(3): 379-391
Schuster, H.; Wienker, T.F.; Toka, H.R.; Bähring, S.; Jeschke, E.; Toka, O.; Busjahn, A.; Hempel, A.; Tahlhammer, C.; Oelkers, W.; Kunze, J.; Bilginturan, N.; Haller, H.; Luft, F.C. 1996: Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension Hypertension 28(6): 1085-1092
Rupp, H.; Brilla, C.G. 1995: Experimental types of hypertension--models for essential hypertension in the human? Herz 20(5): 315-321
Kirchner, D.; Wiedersberg, H. 1970: Clinical evaluation of renal hypertension in comparison to essential hypertension Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(19): 874-878
Wu, G.; Wen, Y.; Chen, M.; Zhang, S.; Zhou, L. 1991: An antihypertensive factor in the erythrocytes of essential hypertensive subjects Chinese Medical Sciences Journal 6(2): 122
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Sokolova, L.A.; Bondarenko, B.B.; Evdokimova, T.A. 1992: Comparative evaluation of cardiovascular system reactivity in patients with borderline arterial hypertension and the early stages of essential hypertension Fiziologiia Cheloveka 18(1): 128-135
Qasim, A.; Bashir, A.; Sajid, S.; Riaz, M.M.; Almas, A. 2016: Women with pregnancy induced hypertension have a higher risk of developing essential hypertension - a case control study from a tertiary care center in Pakistan JPMA. Journal of the Pakistan Medical Association 66(2): 179-183
Rorbaek Madsen, P.E.; Buch, J. 1971: Transient hypertension--precursor of essential hypertension? Ugeskrift for Laeger 133(14): 637-640
Brown, M.J.; Causon, R.C.; Barnes, V.F.; Brennan, P.; Barnes, G.; Greenberg, G. 1985: Urinary catecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council trial for mild hypertension and from matched controls Quarterly Journal of Medicine 57(222): 637-651
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Marec, J.; Keprtová, J.; Spurná, V.; Minárová, E.; Michl, J. 1978: The effect of growth-promoting alpha-globulin (GPAG) on the incorporation of exogenous DNA into L-cells. I. Incorporation of isologous and heterologous 3H-DNA Neoplasma 25(1): 37-46